AP NEWS

SHAREHOLDER ALERT: RMTI TTPH NLSN TSLA PDD AMPE NVRO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

August 28, 2018

NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Rockwell Medical, Inc. (NASDAQ: RMTI) Lead Plaintiff Deadline: September 25, 2018 Class Period: March 16, 2018 and June 26, 2018

Get additional information about RMTI: http://www.wongesq.com/pslra-c/rockwell-medical-inc?wire=3

Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) Lead Plaintiff Deadline: September 25, 2018 Class Period: (1) Pursuant and/or traceable to the July 2017 Secondary Offering and/or (2) between March 8, 2017 and February 13, 2018

Get additional information about TTPH: http://www.wongesq.com/pslra-c/tetraphase-pharmaceuticals-inc?wire=3

Nielsen Holdings plc (NYSE: NLSN) Lead Plaintiff Deadline: October 9, 2018 Class Period: February 8, 2018 and July 25, 2018

Get additional information about NLSN: http://www.wongesq.com/pslra-c/nielsen-holdings-plc?wire=3

Tesla, Inc. (NASDAQ: TSLA) Lead Plaintiff Deadline: October 9, 2018 Class Period: Purchasers of shares between August 7, 2018 and August 14, 2018 and/or who had open short positions or put options for Tesla as of August 7, 2018 or August 8, 2018

Get additional information about TSLA: http://www.wongesq.com/pslra-1/tesla-inc-loss-submission-form?wire=3

Pinduoduo Inc. (NASDAQ: PDD) Lead Plaintiff Deadline: October 22, 2018 Class Period: Pursuant to the July 26, 2018 initial public offering

Get additional information about PDD: http://www.wongesq.com/pslra-1/pinduoduo-inc-loss-form?wire=3

Ampio Pharmaceuticals, Inc. (NYSEAmerican: AMPE) Lead Plaintiff Deadline: October 24, 2018 Class Period: December 14, 2017 and August 7, 2018

Get additional information about AMPE: http://www.wongesq.com/pslra-1/ampio-pharmaceuticals-inc-loss-form?wire=3

Nevro Corp. (NYSE: NVRO) Lead Plaintiff Deadline: October 22, 2018 Class Period: January 8, 2018 and July 12, 2018

Get additional information about NVRO: http://www.wongesq.com/pslra-1/nevro-corp-loss-submission-form?wire=3

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:Vincent Wong, Esq.39 East BroadwaySuite 304New York, NY 10002Tel. 212.425.1140Fax. 866.699.3880E-Mail: vw@wongesq.com

AP RADIO
Update hourly